Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. (12th March 2018) - Castillo, Jorge J.; Guerrero‐Garcia, Thomas; Baldini, Francesco; Tchernonog, Emmanuelle; Cartron, Guillaume; Ninkovic, Slavisa; Cwynarski, Kate; Dierickx, Daan; Tousseyn, Thomas; Lansigan, Frederick; Linnik, Yevgeny; Mogollon, Renzo; et al.